AZD1208 is a highly selective and potent pan-PIM kinase inhibitor (IC50 = 3 nM PIM1, 150 nM PIM2, 9 nM PIM3).1 Displayed efficacy in models of acute myeloid leukemia2, prostate cancer3, and triple-negative breast cancer4. Combination treatment of AZD1208
* VAT and and shipping costs not included. Errors and price changes excepted